192 related articles for article (PubMed ID: 72033)
1. Thrombotest mixing experiments in congenital coagulation disorders of the prothrombin complex and in coumarin treated patients. An additional evidence against the presence of an inhibitor in the latter.
Girolami A; Patrassi O; Cella G
Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(3):463-70. PubMed ID: 72033
[TBL] [Abstract][Full Text] [Related]
2. Normotest--thrombotest discrepancy in congenital coagulation disorders of the prothrombin complex and in coumarin-treated patients: a nonspecific phenomenon.
Girolami A; Brunetti A; Patrassi GM
Am J Clin Pathol; 1977 Jan; 67(1):57-60. PubMed ID: 831455
[TBL] [Abstract][Full Text] [Related]
3. Glass activation-induced decrease or disappearance of normotest-thrombotest discrepancy in congenital coagulation disorders of the prothrombin complex.
Girolami A; Patrassi G; Fabris F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(2):283-93. PubMed ID: 69593
[TBL] [Abstract][Full Text] [Related]
4. [Mixing test for prolonged clotting time: clinical availability and problems].
Uchiba M; Ando Y
Rinsho Byori; 2009 Oct; 57(10):1004-12. PubMed ID: 19928499
[TBL] [Abstract][Full Text] [Related]
5. Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.
Thompson AR
J Clin Invest; 1977 May; 59(5):900-10. PubMed ID: 856873
[TBL] [Abstract][Full Text] [Related]
6. Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasma.
Orstavik KH
Thromb Haemost; 1981 Dec; 46(4):684-6. PubMed ID: 7330818
[TBL] [Abstract][Full Text] [Related]
7. Detection of procoagulant phospholipid interfering in tests for lupus anticoagulant.
Exner T; Low J
Thromb Res; 2004; 114(5-6):547-52. PubMed ID: 15507290
[TBL] [Abstract][Full Text] [Related]
8. Apparent decrease of "inhibition" in the dilution curve system with the increase of anticoagulation. A paradox that is against the presence of inhibitors in coumarin treated patients.
Girolami A; Fabris F; dal Bo Zanon R; Cappellato G
Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(5):670-6. PubMed ID: 75136
[TBL] [Abstract][Full Text] [Related]
9. Improved coagulation in bleeding disorders by Non-Anticoagulant Sulfated Polysaccharides (NASP).
Liu T; Scallan CD; Broze GJ; Patarroyo-White S; Pierce GF; Johnson KW
Thromb Haemost; 2006 Jan; 95(1):68-76. PubMed ID: 16543964
[TBL] [Abstract][Full Text] [Related]
10. Apparent "inhibition" as tested by means of the dilution curve system in patients with clotting defect due to liver damage.
Girolami A; Dal Bo Zanon R; Sticchi A
Blut; 1977 Sep; 35(3):247-52. PubMed ID: 912109
[TBL] [Abstract][Full Text] [Related]
11. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
Galli M; Beretta G; Daldossi M; Bevers EM; Barbui T
Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999
[TBL] [Abstract][Full Text] [Related]
12. Microplate coagulation assays.
Pratt CW; Monroe DM
Biotechniques; 1992 Sep; 13(3):430-3. PubMed ID: 1389175
[TBL] [Abstract][Full Text] [Related]
13. [Control of anticoagulant therapy with coumarin derivatives. Evolution of the tests used and their standardization].
Recalcati P; Perini A; Binda A
Arch Sci Med (Torino); 1979; 136(3):369-84. PubMed ID: 398692
[TBL] [Abstract][Full Text] [Related]
14. Levels of acarboxy prothrombin (PIVKA-II) and coagulation factors in warfarin-treated patients.
Umeki S; Umeki Y
Med Lab Sci; 1990 Apr; 47(2):103-7. PubMed ID: 2381266
[TBL] [Abstract][Full Text] [Related]
15. [Hepato-quick--a new thromboplastin time system: a comparison with normotest and thrombotest (author's transl)].
Fischer M; Falkensammer C
Wien Klin Wochenschr; 1974 Oct; 86(19):577-83. PubMed ID: 4432516
[No Abstract] [Full Text] [Related]
16. [Statistical comparison between prothrombin time, Owren's thrombotest and cephalin time during the surveillance of anticoagulant therapy].
Aznar J; Fernández Pavón A; Aznar JA
Sangre (Barc); 1972; 17(2):187-92. PubMed ID: 5035457
[No Abstract] [Full Text] [Related]
17. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied.
Moore GW; Savidge GF
Thromb Res; 2006; 118(4):523-8. PubMed ID: 16263154
[TBL] [Abstract][Full Text] [Related]
18. Hypothermia and blood coagulation: dissociation between enzyme activity and clotting factor levels.
Reed RL; Bracey AW; Hudson JD; Miller TA; Fischer RP
Circ Shock; 1990 Oct; 32(2):141-52. PubMed ID: 2253317
[TBL] [Abstract][Full Text] [Related]
19. The dilute phospholipid APTT: a sensitive assay for verification of lupus anticoagulants.
Alving BM; Baldwin PE; Richards RL; Jackson BJ
Thromb Haemost; 1985 Oct; 54(3):709-12. PubMed ID: 3937268
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma.
Nordfang O; Valentin S; Beck TC; Hedner U
Thromb Haemost; 1991 Oct; 66(4):464-7. PubMed ID: 1796397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
